Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip L De Jager

Showing results (1-10 of 574) with videos related to

Pageof 58
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 19, 2017
The era of GWAS is over - NoPhilip L De Jager
Neurobiology of Disease|March 12, 2021
Deconstructing the epigenomic architecture of human neurodegenerationPhilip L De Jager
Therapeutic Advances in Neurological Disorders|December 25, 2010
Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the futurePhilip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 12, 2018
Is the goal of an epigenomic study to determine causality?Philip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2018
Designing an epigenomic studyYiyi Ma, Philip L De Jager
Molecular Psychiatry|June 6, 2022
Neuroimmune contributions to Alzheimer's disease: a focus on human dataVerena Haage, Philip L De Jager
Continuum (Minneapolis, Minn.)|July 20, 2012
Uncovering the genetic architecture of multiple sclerosisFederica Esposito, Philip L De Jager
Journal of Neuroimmunology|February 3, 2012
Exploring the role of the epigenome in multiple sclerosis: a window onto cell-specific transcriptional potentialAnna Kaliszewska, Philip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2018
Evaluating the role of genetic variation in the epigenome in health and diseaseTina Roostaei, Philip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2018
What is the epigenome and is it involved in multiple sclerosis?Ji Y Lee, Philip L De Jager
Pageof 58

Showing results (1-10 of 574) with videos related to

Sort By:
Pageof 58
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 19, 2017
The era of GWAS is over - NoPhilip L De Jager
Neurobiology of Disease|March 12, 2021
Deconstructing the epigenomic architecture of human neurodegenerationPhilip L De Jager
Therapeutic Advances in Neurological Disorders|December 25, 2010
Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the futurePhilip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 12, 2018
Is the goal of an epigenomic study to determine causality?Philip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2018
Designing an epigenomic studyYiyi Ma, Philip L De Jager
Molecular Psychiatry|June 6, 2022
Neuroimmune contributions to Alzheimer's disease: a focus on human dataVerena Haage, Philip L De Jager
Continuum (Minneapolis, Minn.)|July 20, 2012
Uncovering the genetic architecture of multiple sclerosisFederica Esposito, Philip L De Jager
Journal of Neuroimmunology|February 3, 2012
Exploring the role of the epigenome in multiple sclerosis: a window onto cell-specific transcriptional potentialAnna Kaliszewska, Philip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2018
Evaluating the role of genetic variation in the epigenome in health and diseaseTina Roostaei, Philip L De Jager
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2018
What is the epigenome and is it involved in multiple sclerosis?Ji Y Lee, Philip L De Jager
Pageof 58